Impact of RYGB surgery on plasma immunoglobulins: association between blood pressure and glucose levels six months after surgery

APMIS. 2024 Mar;132(3):187-197. doi: 10.1111/apm.13366. Epub 2023 Dec 27.

Abstract

We aimed to study levels of natural antibodies in plasma, and their associations to clinical and fecal biomarkers, before and 6 months after Roux-en-Y gastric bypass (RYGB) surgery. Thirty individuals with obesity [16 type 2 diabetic, 14 non-diabetic (ND)] had RYGB surgery. Total plasma IgA, IgG and IgM antibody levels and specific antibodies to oxidized low-density lipoprotein (oxLDL), malondialdehyde-acetaldehyde adducts, Porphyromonas gingivalis gingipain A hemagglutinin domain (Rgp44), and phosphocholine were measured using chemiluminescence immunoassay. Associations between plasma and fecal antibodies as well as clinical markers were analyzed. RYGB surgery reduced blood pressure, and the glycemic state was improved. A higher level of diastolic blood pressure was associated with lower plasma antibodies to oxLDL after surgery. Also, lower level of glucose markers associated with lower level of plasma antibodies to bacterial virulence factors. Antibodies to oxLDL decreased after surgery, and positive association between active serum lipopolysaccharide and specific oxLDL antibodies was detected. Total IgG levels decreased after surgery, but only in ND individuals. Reduced level of total plasma IgG, improved state of hypertension and hyperglycemia and their associations with decreased levels of specific antibodies in plasma, suggest an improved state of systemic inflammation after RYGB surgery.

Keywords: Roux-en-Y gastric bypass surgery; immunoglobulins; natural antibodies; obesity.

MeSH terms

  • Blood Glucose
  • Blood Pressure
  • Diabetes Mellitus, Type 2*
  • Gastric Bypass*
  • Glucose
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M

Substances

  • Blood Glucose
  • Glucose
  • Immunoglobulin M
  • Immunoglobulin G